利用稳态可塑性治疗抑郁症
重性抑郁障碍异质性高,难以开发普适药物。NMDAR拮抗剂单次注射后数小时内快速改善抑郁症状,其作用依赖激活蛋白合成依赖的稳态机制恢复自上而下的兴奋性连接,形成新突触增加兴奋驱动,需mTORC1通路。综述还强调GABABR功能由抑制转为兴奋是mTORC1依赖翻译所必需。
要点
- NMDAR拮抗剂通过激活蛋白合成依赖的稳态机制快速抗抑郁。
- 新突触形成增加兴奋驱动需要mTORC1信号通路调控突触蛋白合成。
- GABABR功能由抑制转为兴奋是NMDAR拮抗剂诱导mTORC1依赖翻译的必要条件。
核心结论
- NMDAR拮抗剂作为快速起效抗抑郁药,通过激活稳态可塑性机制恢复兴奋性连接并形成新突触。
- GABABR功能由抑制转为兴奋是mTORC1依赖翻译及NMDAR拮抗剂抗抑郁作用的关键环节。
研究设计与样本
- 本文为综述,汇总关于NMDAR拮抗剂作为快速起效抗抑郁药及稳态机制的研究。
主要发现
- NMDAR拮抗剂单次注射后数小时内缓解抑郁症状。
- 其作用依赖激活蛋白合成依赖的稳态机制,恢复自上而下的兴奋性连接。
- NMDAR拮抗剂通过形成新突触增加兴奋驱动,该过程需要mTORC1调控突触蛋白合成。
- GABABR功能由抑制转为兴奋是mTORC1依赖翻译所必需。
临床怎么用
- 临床可关注NMDAR拮抗剂快速抗抑郁效应及其依赖的稳态可塑性机制。
- mTORC1通路和GABABR功能转换可作为潜在治疗靶点研究方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Major depressive disorder (MDD) is a complex and heterogeneous mood disorder, making it difficult to develop a generalized, pharmacological therapy that is effective for all who suffer from MDD. Through the fortuitous discovery of N-methyl-D-aspartate receptor (NMDAR) antagonists as effective antidepressants, we have gained key insights into how antidepressant effects can be produced at the circuit and molecular levels. NMDAR antagonists act as rapid-acting antidepressants such that relief from depressive symptoms occurs within hours of a single injection. The mode of action of NMDAR antagonists seemingly relies on their ability to activate protein-synthesis-dependent homeostatic mechanisms that restore top-down excitatory connections. Recent evidence suggests that NMDAR antagonists relieve depressive symptoms by forming new synapses resulting in increased excitatory drive. This event requires the mammalian target of rapamycin complex 1 (mTORC1), a signaling pathway that regulates synaptic protein synthesis. Herein, we review critical studies that shed light on the action of NMDAR antagonists as rapid-acting antidepressants and how they engage a neuron's or neural network's homeostatic mechanisms to self-correct. Recent studies notably demonstrate that a shift in γ-amino-butyric acid receptor B (GABABR) function, from inhibitory to excitatory, is required for mTORC1-dependent translation with NMDAR antagonists. Finally, we discuss how GABABR activation of mTORC1 helps resolve key discrepancies between rapid-acting antidepressants and local homeostatic mechanisms.
引用
- Workman ER, Niere F, Raab-Graham KF, et al. Engaging homeostatic plasticity to treat depression. Mol Psychiatry. 2017. PMID: 29133952. doi:10.1038/mp.2017.225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。